A
Arcturus Therapeutics
San Diego, United States
Founded 2013 NASDAQ: ARCT
About
Developer of LUNAR lipid nanoparticle delivery platform for mRNA medicines
Company Details
- Type
- commercial
- Employees
- 100-200
- Funding
- Public
Key Products
- LUNAR LNP Technology
- ARCT-154